Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Using AFM to study cell mechanics and function

Using AFM to study cell mechanics and function

Wake Forest Baptist scientists win grant to develop more effective treatments for brain cancer

Wake Forest Baptist scientists win grant to develop more effective treatments for brain cancer

Researchers to investigate cellular changes leading to development of glioblastoma

Researchers to investigate cellular changes leading to development of glioblastoma

Scientists validate biomarker indicative of brain cancer patient's prognosis and drug response

Scientists validate biomarker indicative of brain cancer patient's prognosis and drug response

UCLA scientists discover potential combination treatment for brain cancer in adults

UCLA scientists discover potential combination treatment for brain cancer in adults

RCSI-led study aims to train next generation of brain cancer researchers

RCSI-led study aims to train next generation of brain cancer researchers

Poliovirus therapy triggers longer-lasting immune response against malignant tumors

Poliovirus therapy triggers longer-lasting immune response against malignant tumors

Study: Genomic profiling could help identify effective treatments for pediatric gliomas

Study: Genomic profiling could help identify effective treatments for pediatric gliomas

FDA grants approval for new biosimilar to treat multiple types of cancer

FDA grants approval for new biosimilar to treat multiple types of cancer

Patients diagnosed with glioblastoma benefit from care at high-volume centers, study suggests

Patients diagnosed with glioblastoma benefit from care at high-volume centers, study suggests

Zika virus found to specifically kill glioblastoma brain cancer cells

Zika virus found to specifically kill glioblastoma brain cancer cells

Zika virus may one day be effective treatment for deadly brain cancer

Zika virus may one day be effective treatment for deadly brain cancer

London Freemasons award grant to medical charity to support scientists looking to cure brain tumors

London Freemasons award grant to medical charity to support scientists looking to cure brain tumors

Researchers identify new factors that may affect brain tumor cells' ability to resist treatment

Researchers identify new factors that may affect brain tumor cells' ability to resist treatment

Moffitt Cancer Center and Cvergenx form research partnership to revolutionize radiation therapy

Moffitt Cancer Center and Cvergenx form research partnership to revolutionize radiation therapy

NYITCOM research could potentially lead to more effective, less toxic cancer treatment

NYITCOM research could potentially lead to more effective, less toxic cancer treatment

Promising brain cancer vaccine developed at Roswell Park receives orphan drug status from FDA

Promising brain cancer vaccine developed at Roswell Park receives orphan drug status from FDA

Neuro-oncology scientists discover unique molecular mechanism that maintains glioma stem cells

Neuro-oncology scientists discover unique molecular mechanism that maintains glioma stem cells

Researchers devise strategy to target Achilles heel of nervous system cancers

Researchers devise strategy to target Achilles heel of nervous system cancers

Scientists discover how CD44s molecule gives brain cancer cells a survival advantage

Scientists discover how CD44s molecule gives brain cancer cells a survival advantage